Cada vez somos mães mais tarde. E gravidezes mais tardias implicam maior risco para mãe e bebé. A idade biológica mais segura para parir está mt abaixo da idade em que, hoje, a maioria de nós tem os primeiros filhos. +
Presented at #ACC25:
Among adults with pulmonary arterial hypertension at high risk for death, sotatercept reduced the risk of a composite of death from any cause, lung transplantation, or pulmonary arterial hypertension. Full ZENITH trial results: https://t.co/IJylpCyw6r
@ACCinTouch
We are very proud of our interns our @FBAlbuq and @Ines_FNeves for their outstanding clinical case presentations that led to their recognition as the best presentation in Coronary and Structural interventional Cardiology cases at the 15th @APIC_pt congress in Peniche 🫀 🇵🇹
It’s #CTEPH Awareness Day! Anyone w/ unexplained or post-PE dyspnea should be evaluated for CTEPH + candidacy for #PTE or #BPA. PTE was pioneered at UCSD >50y ago and now >5000 pts @UCSDHealth have had their lives changed w/ PTE! @ucsdpccm@UCSDCardiology
https://t.co/2JSS4ezWsq
🚨Out Now in @jcardfail: In 2021, #JCF implemented a double-blind review process hoping to reduce bias. Initial observations?🔥
Female first authorship ⬆️
Female senior authorship ↔️
#HFSA2024
🔗https://t.co/8voe69fjP1
@EMDeFilippisMD
UCSD’s CTEPH Program is on FIRE! 🔥We just hit a MAJOR milestone: 1000 balloon pulmonary angioplasty sessions with ZERO mortality! 🤯 That’s right, zero. Compared to published rates up to 3%, this is unheard of. #UCSD#CTEPH#medicalbreakthrough#proudmoment#BPA#PTE
Congratulations to our ⭐️ intern Francisco Albuquerque on publishing his first article on the impact Aortic Valvuloplasty as a Bridging Therapy -
https://t.co/O9UGDYgdss
O primogénito 👶
Very happy to share the work of our team @EP_HSMarta at @HSMarta_Cardio
Epicardial adipose tissue volume assessed by cardiac CT as a predictor of atrial fibrillation recurrence following catheter ablation - Clinical Imaging https://t.co/bZWYqdstuf